Stock SXTC CHINA SXT PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Market Closed - Nasdaq
Other stock markets
 20:59:20 25/06/2024 BST 		5-day change 1st Jan Change
1.14 USD +4.59% Intraday chart for China SXT Pharmaceuticals, Inc. +5.55% -71.28%
05-13 China SXT Pharmaceuticals, Inc. announced that it has received $0.75 million in funding from Streeterville Capital, LLC CI
05-09 China SXT Pharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding from Streeterville Capital, LLC CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
China SXT Pharmaceuticals : May 2024 Note - Form 6-K
PU
China SXT Pharmaceuticals : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K
PU
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
AQ
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
AQ
China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
AQ
China SXT Pharmaceuticals : Purchase Agreement - Form 6-K
PU
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K
PU
China SXT Pharmaceuticals : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K
PU
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K
PU
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
AQ
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K
PU
China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split
GL
China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split
AQ
China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million
GL
China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million
GL
China SXT Pharmaceuticals : Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares - Form 6-K
PU
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment
AQ
China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
GL
China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
GL
China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SXTC Stock
  4. News China SXT Pharmaceuticals, Inc.
  5. Press Releases